Infants' ibuprofen recalled because of potential high potency

Eric Walter
December 06, 2018 - 7:35 am
Three lots of infant ibuprophen have been recalled.

PR Newsfoto / Tris Pharma, Inc.

Categories: 

PHILADELPHIA (KYW Newsradio) — Tris Pharma, Inc., based in Monmouth Junction, N.J., has voluntarily recalled three lots of ibuprofen for infants. The recalled products may have concentrations of ibuprofen that are too high.

To date there are no reports of any injury or illness from this pain reliever/fever reducer. However, the drugmaker says there is a remote possibility that infants, who are more susceptible to a higher-potency level of the drug, may be vulnerable to kidney injury. 

Symptoms that may occur include: nausea, vomiting, chest pain, and, more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible. Anyone who has experienced any problems should contact their doctor or healthcare provider.

The product is packaged in 0.5 oz. bottles. The three lots, sold at Wal-Mart, CVS Pharmacy, and Family Dollar, are listed below:

Wal-Mart
Equate: Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle

  • Lot No. 00717009A, expires 02/19
  • Lot No. 00717015A, expires 04/19
  • Lot No. 00717024A, expires 08/19

CVS Pharmacy
CVS Health: Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle

  • Lot No. 00717024A, expires 08/19

Family Dollar
Family Wellness: Infants' Ibuprofen Concentrated Oral  Suspension, USP (NSAID), 50 mg per 1.25 mL, 0.5 oz. bottle 

  • Lot No. 00717024A, expires 08/19

Anyone with questions about the recall can call 732-940-0358 or email [email protected].